These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8461762)

  • 1. ACE inhibitors after myocardial infarction.
    Vannan MK; Taylor DJ; Webb-Peploe MM; Konstam MA
    BMJ; 1993 Feb; 306(6877):531-2. PubMed ID: 8461762
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical issues for the use of ACE inhibitors in acute myocardial infarction.
    Testa M; Sonnenblick EH; Lejemtel TH
    J Cardiovasc Risk; 1995 Oct; 2(5):429-33. PubMed ID: 8749270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial infarction: ACE inhibitors for all? For ever?
    Simoons ML
    Lancet; 1994 Jul; 344(8918):279-81. PubMed ID: 7980780
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug differences between ACE inhibitors in experimental settings and clinical practice.
    Voors AA; Kingma JH; van Gilst WH
    J Cardiovasc Risk; 1995 Oct; 2(5):413-22. PubMed ID: 8749268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular remodeling after acute myocardial infarction.
    Pfeffer MA
    Annu Rev Med; 1995; 46():455-66. PubMed ID: 7598478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of angiotensin converting enzyme inhibitors in asymptomatic patients with left ventricular dysfunction after myocardial infarction.
    Bazunga M
    Conn Med; 1995 Nov; 59(11):663-6. PubMed ID: 8565511
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment with ACE inhibitors after acute myocardial infarction].
    Haghfelt T; Thayssen P
    Ugeskr Laeger; 1993 Feb; 155(7):492-3. PubMed ID: 8465457
    [No Abstract]   [Full Text] [Related]  

  • 9. An ACE inhibitor after a myocardial infarction.
    Med Lett Drugs Ther; 1994 Aug; 36(928):69-70. PubMed ID: 8035753
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors: congestive heart failure and beyond.
    Lombardi WL; Litwin SE
    Coron Artery Dis; 1999 Sep; 10(6):361-8. PubMed ID: 10474785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial.
    Singh SN; Karasik P; Hafley GE; Pieper KS; Lee KL; Wyse DG; Buxton AE;
    Am J Cardiol; 2001 Mar; 87(6):716-20. PubMed ID: 11249889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of angiotensin-converting enzyme inhibitors after acute myocardial infarction.
    Mehra IV; Wilson MD
    Pharmacotherapy; 1993; 13(5):440-6. PubMed ID: 8247909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials.
    Latini R; Maggioni AP; Flather M; Sleight P; Tognoni G
    Circulation; 1995 Nov; 92(10):3132-7. PubMed ID: 7586285
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical benefit of angiotensin converting enzyme inhibition after acute myocardial infarction: myocardial reperfusion revisited.
    Renkin J
    J Hypertens Suppl; 1996 Dec; 14(6):S15-9. PubMed ID: 9023710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age.
    Krumholz HM; Vaccarino V; Ellerbeck EF; Kiefe C; Hennen J; Kresowik TF; Gold JA; Jencks SF; Radford MJ
    Am J Cardiol; 1997 Mar; 79(5):581-6. PubMed ID: 9068512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early initiation of ACE inhibitor treatment after acute myocardial infarction--a missed therapeutic opportunity?
    Waring WS
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):245-51. PubMed ID: 11881032
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
    Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R
    Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of congestive heart failure by ACE inhibition in patients with acute myocardial infarction.
    Sigurdsson A; Swedberg K
    J Cardiovasc Risk; 1995 Oct; 2(5):406-12. PubMed ID: 8749267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valsartan an alternative to ACE inhibitor in high-risk MI.
    Geriatrics; 2004 Jan; 59(1):45. PubMed ID: 14755870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.